Lilly(Eli) & Co (NYSE: LLY) kicked off on Friday, down -2.25% from the previous trading day, before settling in for the closing price of $751.45. Over the past 52 weeks, LLY has traded in a range of $677.09-$972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.54%. While this was happening, its average annual earnings per share was recorded 68.86%. With a float of $849.76 million, this company’s outstanding shares have now reached $948.10 million.
Let’s determine the extent of company efficiency that accounts for 47000 employees. In terms of profitability, gross margin is 81.7%, operating margin of 41.41%, and the pretax margin is 27.75%.
Lilly(Eli) & Co (LLY) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Lilly(Eli) & Co is 10.34%, while institutional ownership is 78.89%. The most recent insider transaction that took place on Mar 13 ’25, was worth 1,643,720. Before that another transaction happened on Mar 13 ’25, when Company’s SVP, Finance, & CAO sold 1,000 for $818.24, making the entire transaction worth $818,240. This insider now owns 5,840 shares in total.
Lilly(Eli) & Co (LLY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 68.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.61% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Take a look at Lilly(Eli) & Co’s (LLY) current performance indicators. Last quarter, stock had a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.21. Likewise, its price to free cash flow for the trailing twelve months is 186.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 12.07, a number that is poised to hit 5.54 in the next quarter and is forecasted to reach 29.83 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Looking closely at Lilly(Eli) & Co (NYSE: LLY), its last 5-days average volume was 4.58 million, which is a jump from its year-to-date volume of 3.93 million. As of the previous 9 days, the stock’s Stochastic %D was 4.44%. Additionally, its Average True Range was 35.63.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 22.23%, which indicates a significant increase from 0.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.86% in the past 14 days, which was higher than the 45.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $819.89, while its 200-day Moving Average is $840.77. However, in the short run, Lilly(Eli) & Co’s stock first resistance to watch stands at $753.39. Second resistance stands at $772.20. The third major resistance level sits at $782.40. If the price goes on to break the first support level at $724.38, it is likely to go to the next support level at $714.18. Should the price break the second support level, the third support level stands at $695.37.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
The company with the Market Capitalisation of 696.18 billion has total of 947,736K Shares Outstanding. Its annual sales at the moment are 45,043 M in contrast with the sum of 10,590 M annual income. Company’s last quarter sales were recorded 12,729 M and last quarter income was 2,759 M.
